期刊文献+

疫苗衍生脊髓灰质炎病毒相关病例的研究进展 被引量:4

Progress in research on vaccine derived polio virus related polio case
原文传递
导出
摘要 目的了解脊髓灰质炎(脊灰)疫苗衍生病毒(VDPV)的发生情况和影响因素,探讨降低VDVP发生的有效措施。方法对口服脊灰减毒活疫苗(OPV)引发的VDVP的分类、发生情况,病毒型别分布,人群分布,OPV免疫剂次与VDVP发生的关系进行综述。结果全球已报告多起疫苗相关性脊灰事件,病毒型别主要为Ⅱ型,其次为Ⅰ型。VDVP的发生主要与疫苗株病毒的基因突变、重组有关。机体免疫缺陷者更易发生。结论在消灭脊灰的后期,消除VDVP将成为消灭脊灰的重要工作内容,为此,有关学者建议停止使用OPV,改用脊灰灭活疫苗或两种疫苗相结合的序贯免疫程序。 Objective To understand the incidence of vaccine derived polio virus (VDPV) related polio and related factors and provide evidence for VDPV related polio prevention and control. Methods Literature review on oral polio vaccine (OPV) caused polio was conducted to understand the incidence of VDPV related polio, population distribution and virus types. Results Vaccine associated paralytic poliomyelitis cases have been reported in the world, which were mainly caused by polio virus type II and type I VDPV were the result of the gene mutation and genetic recombination of vaccine strain virus. Persons who are immune defect are prone to be affected by VDPV. Conclusion VDPV eradication is essential in the late stage of polio eradication. Some scholars have suggested to use inactivated polio vaccine (IPV) instead of OPV, or the combination of OPV and IPV
作者 陈明文 李文
出处 《疾病监测》 CAS 2014年第3期243-246,共4页 Disease Surveillance
关键词 口服脊髓灰质炎病毒疫苗 疫苗衍生脊髓灰质炎病毒相关病例 基因突变 基因重组 oral polio vaccine vaccine derived polio virus related polio case gene mutation genetic recombination
  • 相关文献

参考文献26

  • 1Kew OM, Sutter RW, de Gourville EM, et al. Vaccine-derived polioviruses and the endgarne strategy for global polio eradication [ J ]. Annu Rev Microbiol,2005,59:587 - 635.
  • 2Centers for Disease Control and Prevention. Laboratory surveillance for wild and vaccine-derived polio-viruses-worldwide, January 2006-June 2007 [ J ]. MMWR,2007,56 ( 37 ) 965 - 969.
  • 3Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed [ J ]. Am J Epidemiol,2010,172 ( 11 ) : 1213 - 1229.
  • 4张勇,严冬梅,赵蓉,刘桂艳,祝双利,李杰,王东艳,朱晖,安洪秋,许文波.中国急性弛缓性麻痹病例脊髓灰质炎疫苗病毒分离株中优势株的基因特征及形成原因浅析[J].中国计划免疫,2006,12(3):173-179. 被引量:15
  • 5Update C. Outbreak of poliomyelitis-Dominican Republic and Haiti, 2000 - 2001 [ J]. MMWR, 2001,50 ( 39 ) : 855 - 856.
  • 6Shimizu H, Thorley B, Paladin FJ, et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001[ J]. J Viro, 2004,78(24) :13512 -13521.
  • 7Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, et al. Recombinant vaccine-derived poliovims in Madagascar[ J]. Emerg Infect Dis,2003,9 (7) : 885 - 887.
  • 8liang X, Zhang Y, Xu W, et al. An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China[ J]. J Infect Dis,2006,194(5) :545 -551.
  • 9Yan D, Li L, Zhu S, et al, Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China [ J ]. J Clinl Microbiol, 2010, 48 (9) :3274 - 3280.
  • 10Shahmahmoodi S, Mamishi S, aghamohammadi A, et al. Vaccine associated paralytic poliomyelitis in immunodeficient children, Iran, 1995 - 2008 [ J]. Emerg Infect Dis, 2010, 16 (7) :1133 - 1136.

二级参考文献68

  • 1梁晓峰,童亦兵,冯子健,徐爱强,张丽,张大勇,雷杰,于竞进.中国首次疫苗衍生脊髓灰质炎病毒循环事件的发现及处理[J].中国计划免疫,2005,11(4):245-247. 被引量:56
  • 2刘丹青,李黎,王斌冰,赵月萍,陈晓琴,温宁,梁晓峰,许文波,张勇,严冬梅,周曙,陈霞,谢少煜,沈永刚,陆志坚,唐继海,戴振威.中国首例免疫缺陷疫苗衍生脊髓灰质炎病毒病例的流行病学调查分析及其控制对策[J].中国计划免疫,2006,12(6):459-463. 被引量:46
  • 3Toyoda H, Kohara M, Kataoka Y, et al. Completenu-cleotidesequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants[J]. J Mol Biol, 1984,174(4):561-585.
  • 4Freitadt MS, Eberle KE. Correlation betweenpoliovirus type 1 Mahoney replication in blood cells and neurovirulence [J]. J Virol,1996,70(9):6486-6492.
  • 5Chezzi C, Dommann CJ, Blackburn NK, et al. Genetic stability of oral polio vaccine prepared on primary monkey kidney cells or Vero cells-effects of passage in cell culture and the human gastrointestinal tract[J]. Vaccine, 1998,16(20):2031-2038.
  • 6Friedrich F. Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans[J]. Acta Virol, 1998,42(3):187-194.
  • 7WHO. Polio laboratory manual. 4th ed. [M]. Geneva, Switzerland: WHO, 2004,83-96.
  • 8Mc Ginnis S,Madden TL. BLAST:at thecore of a powerful and iverse set of sequence analysis tools[J]. Nucleic Acids Res,2004, 32(Web Serverissue): W20-25.
  • 9Hall TA. BioEdit:a user-friendly biological sequence alignment editor and analysis programfor Windows 95/98/NT[J]. Nucl Acids Symp, 1999,41:95-98.
  • 10Page RD. TreeView: an application to display phylogenetic trees on personal computers[J]. Comput Appl Biosci, 1996,12(4):357-358.

共引文献31

同被引文献36

  • 1马昌燐.放射性同位素标记核酸探针的方法[J].核科学与工程,1994,14(3):280-283. 被引量:3
  • 2张勇,严冬梅,王东艳,朱贞,刘中华,赵月萍,陈晓琴,祝双利,李崇山,安洪秋,许文波.我国首例iVDPV病例Ⅱ型脊髓灰质炎病毒分离株的基因特征[J].病毒学报,2007,23(3):188-194. 被引量:6
  • 3Diop OM, Burns CC, Wassilak SG, et al. Update on Vaccine- Derived Polioviruses - Worldwide, July 2012 - December 2013 [ J ]. Morbidity and Mortality Weekly Report,2014,63 ( 11 ) :242 - 248.
  • 4De La Torre JC,Tao Z, Zhang Y, et al. Isolation and characterization of a type 2 Vaccine - Derived poliovirus from environmental surveillance in China ,2012 [ J ]. PLOS One ,2013,8 ( 12 ) : e83975.
  • 5Burns CC, Diop OM, Sutter RW, et al. Vaccine - derived polioviruses [ J]. The Journal of infectious diseases, 2014, 210 (Suppl 1 ) : $283 - $293.
  • 6Kew OM, Suttcr RW, Gourville EMD, et al. Vaccine - derived poliovirnses and the endgame strategy for global polio eradication [ J]. Annual Review of Microbiology,2005,59:587 - 635.
  • 7CDC. Laboratory surveillance for wild and vaccine - derived polioviruses, January 2007 - June 2008 [ J]. Releve epidemiologique hebdomadaire / Section d'hygicne du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations,2008,83 ( 36 ) :321 - 328.
  • 8Wringe A, Fine PE, Sutter RW, et al. Estimating the extent of vaccine - derived poliovirus infection [ J ]. PLOS One, 2008, 3 (10) :e3433.
  • 9Platt LR, Esttvariz CF, Sutter RW. Vaccine - associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden [ J ]. The Journal of infectious diseases, 2014,210 ( Suppl 1 ) :$380 - $389.
  • 10Duintjer Tebbens RJ, Thompson KM. Managing the risk of circulating vaccine - derived poliovirus during the endgame: oralpoliovirus vaccine needs [J]. BMC Infectious Diseases, 2015,15 : 390.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部